Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Tsourti Z"'
Autor:
Dafni, U., Soo, R. A., Peters, S., Tsourti, Z., Zygoura, P., Vervita, K., Han, J-Y, De Castro, J., Coate, L., Fruh, M., Hashemi, S. M. S., Nadal, E., Carcereny, E., Sala, M. A., Bernabe, R., Provencio, M., Cuffe, S., Roschitzki-Voser, H., Ruepp, B., Rosell, R., Stahel, R. A.
Background: The ETOP 10-16 BOOSTER trial failed to demonstrate a progression-free survival (PFS) benefit for adding bevacizumab to osimertinib in second line. An exploratory subgroup analysis, however, suggested a PFS benefit of the combination in pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2636::801bc88be8f25f3fa5e318e970392eab
https://hdl.handle.net/10668/22216
https://hdl.handle.net/10668/22216